Recent Headlines
DaVinci Biosciences Announces Publication of "Mesenchymal Stem Cells for the Treatment of Arthritis" in the Book Anti-Aging Therapeutics, Volume 17
DaVinci Biosciences, LLC, a company committed to improving the quality of life for those suffering from degenerative diseases, announced today that the Vice President of Research and Development, Rafael Gonzalez’s, paper “Mesenchymal Stem Cells for the Treatment of Arthritis” has... - August 25, 2015 - DaVinci Biosciences LLC
Molecular Innovations, Inc. Issued U.S. Patent for Human Prorenin ELISA Kit
Molecular Innovations, Inc. has been issued United States Patent Number 9,085,795 for its unique and novel “Human Prorenin ELISA Kit.” - August 23, 2015 - Molecular Innovations
AdvantaPure(R) Welcomes Mark Mistretta as East Coast Sales Manager; Brings Sales and Engineering Experience to Assist Customers with Process System Integration
AdvantaPure announces the appointment of Mark Mistretta to its team. Mistretta fills the east coast sales position vacated due to the recent promotion of another team member. His experience in sales and mechanical engineering will help AdvantaPure’s Single-Use system customers work out their biopharma fluid flow concepts and application challenges. As Eastern Regional Sales Manager, Mistretta is responsible for the management and growth of accounts in the eastern U.S. - August 21, 2015 - AdvantaPure
Free Seminar for Manufacturers of Finished Parts
An educational seminar for manufacturers, custom coaters and fabricators will be held at Century II Performing Arts Center in Wichita, KS on August 28, 2015. This seminar will be helpful for companies who have liquid or powder coating lines. Information about the seminar may be found at... - August 19, 2015 - Kasa Companies
Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech
Israel Patent Office allows patent for treatment of hormone deficiencies and obesity in humans and pets. - August 01, 2015 - Braasch Biotech LLC
Creative BioMart Introduces Oxidative Stress Assay
Creative BioMart, a global leader in the supply of innovative protein research tools and services announced today that it has launched exclusive Oxidative Stress Assay for use in studying many forms of pathophysiology generally associated with aging. Oxidative stress can reflect a disturbance... - June 07, 2015 - Creative BioMart
Linking API Producers to API Customers - Connectivity Matters
The API Sourcing Database is a new Database to find producers of Active Pharmaceutical Ingredients including up to date quality information about the API. - June 02, 2015 - API Sourcing
Glycoscientific Raises the Accuracy and Precision Standard for Glycan Quantitation
GlycoScientific introduces a stable isotope labeled monoclonal antibody (mAb) (iGlycoMabTM) designed to facilitate the accurate and precise quantitative glycan profiling of biological therapeutics, particularly monoclonal antibodies and fusion proteins. However, iGlycoMabTM can be applied to individual glycans or complex mixtures such as those observed in the field of glycomics. - May 30, 2015 - GlycoScientific, LLC
AdvantaPure(R) Welcomes Cuong M. Nguyen as West Coast Sales Manager; Will Handle Account Support, Management and Development
AdvantaPure announces the appointment of Cuong M. Nguyen to its team. Nguyen fills a new position and brings with him many years of experience in sales management, research, application support and business development involving the pharmaceutical manufacturing and biopharma industries. As Western Regional Sales Manager, Nguyen is responsible for the management and growth of accounts in the western U.S. He will also handle accounts for AdvantaPure’s parent company, NewAge Industries. - May 22, 2015 - AdvantaPure
Creative Biomart Launches an Intuitive New Website Design to Enhance User Experience
Creative Biomart, the leading company in the supply of diagnostic antigens and antibodies, pharmaceutical enzymes, diagnostic enzymes, and high-quality recombinant proteins has launched an intuitive new website design as well as coupon promotion. - April 29, 2015 - Creative BioMart
Eagle Biosciences Announces the Launch of Multispecies 25-OH Vitamin D ELISA Assay Kit
Eagle Biosciences, Inc. introduces a simple ELISA to measure both 25-OH Vitamin D2 and D3 equally in multiple species such as bovine, goat, horse, chicken, mouse, rat, rabbit and equine. - April 14, 2015 - Eagle Biosciences, Inc.
AdvantaPure(R) Publishes White Papers on Clean Room Fluid Transfer, Tubing Selection and Container Closures; Topics Address Issues for Pharma and Biopharma Manufacturers
New from tubing and Single-Use System manufacturer AdvantaPure are three white papers focusing on fluid transfer in pharmaceutical and biopharmaceutical applications. The papers focus on incorporating Single-Use practices for clean room fluid transfer, tubing selection, and the importance of container closures. Developed by the company’s application engineers, the reports offer real world examples of critical fluid transfer applications. - April 09, 2015 - AdvantaPure
CytoTest and Uniformed Services University’s Center for Prostate Disease Research Enter Into CRADA to Advance Cancer Diagnosis and Prognosis
CytoTest Inc., the Uniformed Services University of the Health Sciences (USU), and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) announced today that they have signed a Cooperative Research and Development Agreement (CRADA). Under the terms of the CRADA,... - March 31, 2015 - CytoTest Inc.
AveXis EU Ltd. Granted SME Status by the European Medicines Agency
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the European Medicines Agency (EMA) has granted AveXis’ wholly owned European subsidiary,... - March 21, 2015 - AveXis Inc.
Peptineo Announces Appointment of Dr. Panganiban to Peptineo to Serve as Chief Science Officer
Peptineo is pleased to announce that Nito Panganiban, Ph.D., has been named Chief Science Officer at Peptineo. Dr. Panganiban will be responsible for cultivating core research capabilities, establishing product development roadmaps, and for communicating with key scientific and customer communities... - March 20, 2015 - Peptineo
AdvantaPure(R) to Highlight Single-Use Fluid Transfer Innovations at Spring Tradeshows; Includes Appearances in the U.S. and Europe
AdvantaPure will showcase its high purity tubing and Single-Use products at a number of trade shows this spring. Scheduled events will take place in California, New York and Germany. The company will feature its molded manifold assemblies, which are designed to reduce leaks and other risks. Also on hand will be its silicone tubing, AdvantaFlex TPE tubing, AdvantaPass Single-Use fluid transfer technology, BioClosure container closures, process hoses, and hose tracking and identification methods. - March 19, 2015 - AdvantaPure
China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech
China's State Intellectual Property Office to grant Braasch Biotech's patent on Therapeutic treatment of human and pet obesity. - March 13, 2015 - Braasch Biotech LLC
AveXis Announces the Formation of Its European Subsidiary, AveXis EU, Ltd.
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced the formation of its EU-based wholly-owned subsidiary, AveXis EU, Ltd. The subsidiary will allow AveXis... - February 27, 2015 - AveXis Inc.
AnaSpec Launches Industry’s First Amino Acid Pre-loaded Hydrazide Resins
AnaSpec is pleased to announce the launch of the first commercially available Amino Acid Pre-loaded Hydrazide Resins. Native Chemical Ligation (NCL) has been one of the most used bioconjugation methodologies for synthesis of macromolecules. NCL requires a peptide thioester and another peptide... - February 25, 2015 - AnaSpec, EGT Group
AnaSpec Launches Industry’s First Assay for Measuring Matriptase Activity
AnaSpec is pleased to announce the launch of the first commercially available kit for measuring the activity of Matriptase, a protease implicated in carcinogenesis. The SensoLyte® Rh110 Matriptase Assay Kit provides a convenient assay for screening of Matriptase inhibitors and activators or... - February 13, 2015 - AnaSpec, EGT Group
AdvantaPure(R) Invests in Training Its Team Members; Partners with Worcester Polytechnic Institute for Biomanufacturing Training
Employees from AdvantaPure, a manufacturer of high purity tubing and Single-Use components for biopharma manufacturing, recently received customized training at the Biomanufacturing Education and Training Center of Worcester Polytechnic Institute in Worcester, Mass. The training involved classroom and hands-on instruction to teach the employees about the equipment and processes used by their customers in their pharmaceutical and biopharmaceutical manufacturing operations. - February 07, 2015 - AdvantaPure
Local Pharmacy Wants to Warm Those Less Fortunate
Country Village Chemists of Huntington Asks the Public to Support Their Annual Winter Coat Drive. - February 06, 2015 - North Country Drugs
HiLyte™ Your Antibodies Using One Universal Reagent
AnaSpec is pleased to announce the release of a product line of recombinant Protein A, conjugated with HiLyte™ Fluor dyes or Biotin. This universal reagent can be used to detect antibodies from different species, such as human, rabbit, mouse, rat and others. Protein A is available as labeled... - January 30, 2015 - AnaSpec, EGT Group
Boston Healthcare Appoints Andreas H. Sander as Vice President and Managing Director of Boston Healthcare International GmbH
Boston Healthcare today announced the appointment of Andreas Sander as Vice President and Managing Director for Boston Healthcare International GmbH, leading the European team and the firm’s activities in Germany and Europe out of Boston Healthcare’s Berlin office. Mr. Sander brings... - January 21, 2015 - Boston Healthcare
Braasch Biotech Bolsters Intellectual Property with Patent Acceptance in the Philippines
Braasch Biotech LLC continues patent portfolio expansion with new issue in the Philippines. Novel technologies allow safe enhancement of livestock productivity by use of vaccination rather than exogenous pharmaceuticals. - January 15, 2015 - Braasch Biotech LLC
AveXis Closes Its Series C Financing Round with Deerfield Management and Roche Venture Fund
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced it has completed a $10 million financing round led by Deerfield Management and Roche Venture Fund. In... - January 08, 2015 - AveXis Inc.
Good News - Creative Biomart Newly Introduced Fucose-Free Protein Expression System
Creative Biomart, a world leading biotech company that specializes in providing advanced tolls for protein expression and purification, today has officially announced its release of novel service--Fucose-free Protein Expression System. According to its official speaker, this service is supported by... - January 07, 2015 - Creative BioMart
Creative Biomart Launches Special Promotion for Christmas and New Year
Creative Biomart, a world leading biotech company that provides recombinant proteins, enzymes and other quality products and services for customers all over the world, has announced today that they would launch a special promotion for Christmas and New year in this very day. According to its... - December 25, 2014 - Creative BioMart
Creative Biomart Newly Introduced Multiplex Protein Detect Assay
Creative Biomart, a world leading biotech company and the commitment of which is to improving people’s life by assisting scientists with their research, has announced today for its official release of Multiplex Protein Detect Assay Service. This release was said to provide better protein... - December 21, 2014 - Creative BioMart
Clinical and Economic Impact of Next-Generation Sequencing Examined During Boston Healthcare’s Multi-Stakeholder Symposium
Boston Healthcare Associates, Inc. (BHA) and Cambridge Healthtech Institute (CHI) held an engaging, multi-stakeholder symposium surrounding the unique challenges and opportunities with the use of next-generation sequencing (NGS) in oncology care. Entitled, “Capturing the Value of... - December 12, 2014 - Boston Healthcare
AveXis Announces Dosing of First Patient in Intermediate Cohort in Gene Transfer Trial
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the first patient in the intermediate cohort in the Gene Transfer Clinical Trial for SMA Type 1 has... - December 10, 2014 - AveXis Inc.
AveXis Announces Launch of New Patient-Oriented Website Focused on Spinal Muscular Atrophy
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), is pleased to announce the launch of the company’s brand new website specifically focused on SMA: www.smastudy.org. - December 04, 2014 - AveXis Inc.
Creative Biomart’s Most-Favored Services List is Available Now
Creative Biomart, a world leading biotech company that offers recombinant proteins, antibodies, antigens and a wide range of biotech services worldwide, today has released its most favored services list officially. It was said that this was done to make them have a better understanding of what... - November 22, 2014 - Creative BioMart
AveXis to Present at the 26th Annual Piper Jaffray Healthcare Conference
AveXis, a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy, today announced that Mr. John Carbona, Chief Executive Officer, and Dr. Brian Kaspar will present at the 26th Annual Piper Jaffray... - November 21, 2014 - AveXis Inc.
Patent Awarded to AdvantaPure(R)’s AdvantaPass(TM) Clean Room Wall Pass-Through System; Ensures Room Isolation During Fluid Transfer
A United States patent has been awarded to AdvantaPass, a clean room wall pass-through system designed to transfer fluids between clean rooms during pharmaceutical and biopharmaceutical production. The system is the first of its kind to provide complete isolation between manufacturing suites when transferring multiple fluid lines through a single wall portal. AdvantaPass uses Single-Use components, such as tubing and seals, along with durable stainless steel in-wall parts. - November 20, 2014 - AdvantaPure
Enzyme Activity Assay Service Are Available in Creative Biomart
Creative Biomart, a world leading supplier of recombinant proteins, antibodies, enzymes and other biotech services for the research community in the field of biology, has announced today for its official release of the novel service-- Enzyme activity assay. This assay is in the aim of assisting... - November 06, 2014 - Creative BioMart
OutsourcePharma Advisory Board CRO Reviews Database Surpasses Growth Milestone
Online community of outsourcing decision makers doubles its CRO reviews database - October 15, 2014 - Life Science Strategy Group, LLC
Creative Biomart Newly Introduced It’s Fc Fusion Protein Production Service
Creative Biomart, a word leading Biotech Company had newly released its novel service of Fc Fusion Protein Production Service in the aim of providing more choices for the scientists conducting biomedical and immunology research. The potential clinical application of cytokins to modulate immune... - October 10, 2014 - Creative BioMart
AveXis Announces the Completion of Dosing of the Low Dose Cohort in US Clinical Trial for Spinal Muscular Atrophy
AveXis, Inc., a clinic-stage gene therapy company, today announced the completion of dosing in the low dose cohort in the world's first human gene therapy trial for the treatment of infants with spinal muscular atrophy (SMA). The trial (NCT02122952) opened for enrollment in April... - October 08, 2014 - AveXis Inc.
FDAnews Announces: FDA Official Added to 9th Annual FDA Inspections Summit, Oct. 22-24, 2014
9th Annual FDA Inspections Summit Presented by FDAnews; Oct. 22-24, 2014 – Bethesda, MD; www.fdanews.com/InspectionsSummitPR2 - October 05, 2014 - FDAnews
AveXis Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for chariSMA for the Treatment of Spinal Muscular Atrophy
AveXis Inc., a synthetic biology platform company primarily focused on developing treatments for Spinal Muscular Atrophy (SMA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its product scAAV9, called chariSMA to treat Spinal Muscular Atrophy... - October 04, 2014 - AveXis Inc.
Creative Biomart Morning Talk for Mutagenesis Services
Creative BioMart, a world leading Biotech Company, has conducted a morning talk to discuss its mutagenesis. This talk lasted for nearly one hour. Mutagenesis is a fundamentally important DNA manipulation technique. It involves changing the base sequence of the DNA molecule, usually for the... - September 18, 2014 - Creative BioMart
CarpeVITA Natural Products Has Announced It is the Now Exclusive US Distributor of Erba Vita, the Leading Herbal Supplement Brand in Italy
CarpeVITA Natural Products has announced it is the now exclusive US distributor of Erba Vita, the leading herbal supplement brand in Italy and one of Europe's leading brands. All supplements are non-GMO & produced with the highest European standards. - September 15, 2014 - CarpeVITA Natural Products
Creative Biomart Newly Introduced Its Stable Cell Line Service
Creative Biomart today has given an announcement that they would release their new service-stable cell line service in this very day to meet their customer’s need. Stable cell lines are essential for protein and antibody and cell-based assays. But the processes required for the generation of... - September 11, 2014 - Creative BioMart
Creative Biomart Newly Released a Bunch of Over-Expression Lysates
Official marketing staff of Creative Biomart has announced today of their new products release for over-expression lysates. According to its official announcement, this new release is mainly an enhancement of their lysates product. Nearly 9,000 of products have been added in this launch such as... - September 02, 2014 - Creative BioMart
Creative Biomart Introduced Immobilized Enzyme Service
On August 24, 2014, Creative Biomart has introduced their novel service of immobilized enzymes. This novel service is based on a revolutionary new platform, combining affinity tag binding with inert porous materials, designed especially for biocatalysis application in any organic solvent or... - August 27, 2014 - Creative BioMart
Braasch Biotech to Participate at Informa's 9th Annual Veterinary Vaccine Conference
Braasch's Biotech's Dr. Keith Haffer to host seminar on adjuvants at Informa's Veterinary Vaccine Conference in December. - August 25, 2014 - Braasch Biotech LLC
Cheers—Creative Biomart Launches High-Throughput Protein Production
The marketing chief staff of Creative Biomart has announced today that they will release the high-throughput protein production service on this very day in the aim of helping speed up their customer’s protein production project. Protein expression is widely used in the production of... - August 22, 2014 - Creative BioMart
Creative Biomart Launches Novel Service for Protein Labeling
On August 18, Creative Biomart had launched a novel service that is site-specific and custom labeling for protein labeling. This new service includes C-terminal labeling, N-terminal labeling, and Labeling at glycosylation sites. The launch of the site-specific and custom labeling service was said... - August 22, 2014 - Creative BioMart
Creative Biomart Signed Industrial Enzymes Agreement
Creative Biomart signed an Industrial Enzymes Agreement with a UK Industrial giant (the name of the company is not allowed to be exposed according to the agreement). On the basis of this agreement, Creative Biomart is going to provide High-temperature Alpha-amylase for beer, Mid-temperature... - August 20, 2014 - Creative BioMart